The BayWa Group, which carries significant debt, is being forced to undertake a fundamental revision of its recovery roadmap. This strategic pivot follows unexpectedly weak performance from its renewable energy subsidiary, BayWa r.e., creating a substantial shortfall in the parent company’s original deleveraging strategy.
Core Divestment Plan Undermined by Lower Valuations
A central pillar of the conglomerate’s plan to reduce its total debt by approximately €4 billion was the sale of its 51% stake in BayWa r.e., initially projected to yield around €1.7 billion. Current forecasts now point to considerably lower proceeds from any potential divestment, marking a severe blow to the group’s financial planning.
Concurrently, the turnaround schedule for the subsidiary itself has been pushed back by two years. Management now targets completion for 2030, rather than 2028. The operational profit goal, measured by EBITDA, has been revised downward from €230 million to €150 million for that target year.
Should investors sell immediately? Or is it worth buying BayWa?
Strategic Refocus and Crucial Creditor Negotiations
In response to these challenges, BayWa r.e. is largely withdrawing from its U.S. operations to concentrate its future efforts on the European market. At the group level, the publication of the 2025 annual financial statements is expected to be delayed, likely into the fourth quarter of 2026.
Senior executives are currently engaged in intensive discussions with major shareholders and lending banks to establish a standstill agreement. This arrangement is intended to provide the conglomerate with a breathing space until October 2026, securing vital liquidity and allowing time to finalize the details of its revised restructuring concept.
These developments mean the originally envisioned end-date for the restructuring process, set for late 2028, has now moved far into the future. Whether the corporate overhaul can proceed as now envisioned depends critically on securing approval from banks and key investors for the adjusted plan—a decision anticipated by autumn 2026.
Ad
BayWa Stock: Buy or Sell?! New BayWa Analysis from March 12 delivers the answer:
The latest BayWa figures speak for themselves: Urgent action needed for BayWa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 12.
BayWa: Buy or sell? Read more here...
